NSE BSE
morepen lab. ltd stock

MOREPEN LAB. LTD Share Price

- - (%)
- NSE: MOREPENLAB

MOREPEN LAB. LTD Share Price Update

As of the latest trading session, MOREPEN LAB. LTD share price is currently at 56, which is up by 0.45 from its previous closing. Today, the stock has fluctuated between 54.67 and 56.60. Over the past year, MOREPEN LAB. LTD has achieved a return of 83.94 %. In the last month alone, the return has been 5.84 %. Read More...

MOREPEN LAB. LTD Performance

Day Range

Low54.67 High56.60
55.88

52 Week Range

Low 28.60 High 60.75
55.88

MOREPEN LAB. LTD Share Price

2259

500288

MOREPENLAB

img img img img
No Data Available

Open Price

55.85

Prev. Close

55.55

Volume (Shares)

3106397.00

Total traded value

1735.85

Upper Circuit

66.66

Lower Circuit

44.44

Note: The current prices & values are delayed, Login to your account for live updates.

MOREPEN LAB. LTD Fundamentals


(Standalone)

Market Cap (Cr) 2862.54
PE Ratio (TTM) 25.61
Book Value / Share 17.39
Beta 1.30
ROE 6.71%
EPS (TTM) 2.17
Dividend Yield 0.00%
Net Profit Qtr (Cr) 39.96

MOREPEN LAB. LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 392.60
Operating Expense 343.88
Net Profit 39.96
Net Profit Margin (%) 10.17
Earnings Per Share (EPS) 0.78
EBITDA 60.12
Effective Tax Rate (%) 24.18
Particulars DEC 2023 (Values in Cr)
Revenue 394.63
Operating Expense 351.06
Net Profit 35.20
Net Profit Margin (%) 8.91
Earnings Per Share (EPS) 0.69
EBITDA 54.76
Effective Tax Rate (%) 25.45
Particulars SEP 2023 (Values in Cr)
Revenue 381.26
Operating Expense 356.76
Net Profit 19.92
Net Profit Margin (%) 5.22
Earnings Per Share (EPS) 0.39
EBITDA 32.58
Effective Tax Rate (%) 27.11
Particulars JUN 2023 (Values in Cr)
Revenue 369.10
Operating Expense 349.46
Net Profit 15.85
Net Profit Margin (%) 4.29
Earnings Per Share (EPS) 0.31
EBITDA 26.88
Effective Tax Rate (%) 26.99
Particulars MAR 2023 (Values in Cr)
Revenue 336.52
Operating Expense 326.57
Net Profit 10.28
Net Profit Margin (%) 3.05
Earnings Per Share (EPS) 0.20
EBITDA 18.11
Effective Tax Rate (%) 20.63
Particulars MAR 2024 (Values in Cr)
Revenue 1537.59
Operating Expense 1401.18
Net Profit 110.94
Net Profit Margin (%) 7.21
Earnings Per Share (EPS) 2.17
EBITDA 174.39
Effective Tax Rate (%) 25.53
Particulars MAR 2023 (Values in Cr)
Revenue 1338.88
Operating Expense 1281.60
Net Profit 46.24
Net Profit Margin (%) 3.45
Earnings Per Share (EPS) 0.92
EBITDA 83.03
Effective Tax Rate (%) 26.64
Particulars MAR 2022 (Values in Cr)
Revenue 1449.27
Operating Expense 1333.95
Net Profit 101.06
Net Profit Margin (%) 6.97
Earnings Per Share (EPS) 2.25
EBITDA 139.36
Effective Tax Rate (%) 19.49
Particulars MAR 2021 (Values in Cr)
Revenue 1112.42
Operating Expense 1029.95
Net Profit 94.25
Net Profit Margin (%) 8.47
Earnings Per Share (EPS) 2.10
EBITDA 124.15
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 791.99
Operating Expense 763.93
Net Profit 32.33
Net Profit Margin (%) 4.08
Earnings Per Share (EPS) 0.72
EBITDA 73.88
Effective Tax Rate (%) 13.74
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.73
ROE % 5.81
ROCE % 8.02
Total Debt to Total Equity 0.03
EBITDA Margin 6.04
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.56
ROE % 20.27
ROCE % 21.70
Total Debt to Total Equity 0.04
EBITDA Margin 9.50
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.47
ROE % 25.85
ROCE % 20.94
Total Debt to Total Equity 0.21
EBITDA Margin 10.99
Particulars MAR 2020 (Values in Cr)
Book Value / Share 6.32
ROE % 10.24
ROCE % 8.48
Total Debt to Total Equity 0.49
EBITDA Margin 9.14
Particulars MAR 2019 (Values in Cr)
Book Value / Share 5.63
ROE % 8.74
ROCE % 6.49
Total Debt to Total Equity 0.55
EBITDA Margin 9.26
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.26
ROE % 6.71
ROCE % 8.78
Total Debt to Total Equity 0.03
EBITDA Margin 6.20
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.97
ROE % 19.38
ROCE % 20.85
Total Debt to Total Equity 0.03
EBITDA Margin 9.62
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.92
ROE % 24.43
ROCE % 19.57
Total Debt to Total Equity 0.21
EBITDA Margin 11.16
Particulars MAR 2020 (Values in Cr)
Book Value / Share 6.83
ROE % 9.86
ROCE % 8.04
Total Debt to Total Equity 0.48
EBITDA Margin 9.33
Particulars MAR 2019 (Values in Cr)
Book Value / Share 6.17
ROE % 8.67
ROCE % 6.34
Total Debt to Total Equity 0.52
EBITDA Margin 9.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 56.30
Total Assets 1110.49
Total Liabilities 1110.49
Total Equity 752.44
Share Outstanding 511168708
Price to Book Ratio 1.68
Return on Assets (%) 3.48
Return on Capital (%) 4.97
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 45.97
Total Assets 1070.05
Total Liabilities 1070.05
Total Equity 578.10
Share Outstanding 477826203
Price to Book Ratio 3.06
Return on Assets (%) 9.50
Return on Capital (%) 17.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 67.89
Total Assets 858.14
Total Liabilities 858.14
Total Equity 424.29
Share Outstanding 449826203
Price to Book Ratio 3.60
Return on Assets (%) 11.31
Return on Capital (%) 22
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 38.88
Total Assets 663.46
Total Liabilities 663.46
Total Equity 283.59
Share Outstanding 449793203
Price to Book Ratio 1.40
Return on Assets (%) 5.06
Return on Capital (%) 11.35
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 32.21
Total Assets 615.17
Total Liabilities 615.17
Total Equity 252.62
Share Outstanding 449793203
Price to Book Ratio 2.80
Return on Assets (%) 4.68
Return on Capital (%) 10.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 55.90
Total Assets 1105.54
Total Liabilities 1105.54
Total Equity 780.11
Share Outstanding 511168708
Price to Book Ratio 1.68
Return on Assets (%) 4.18
Return on Capital (%) 5.74
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 45.54
Total Assets 1033.26
Total Liabilities 1033.26
Total Equity 598.16
Share Outstanding 477826203
Price to Book Ratio 3.06
Return on Assets (%) 9.78
Return on Capital (%) 16.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 66.98
Total Assets 847.49
Total Liabilities 847.49
Total Equity 444.97
Share Outstanding 449793203
Price to Book Ratio 3.60
Return on Assets (%) 11.12
Return on Capital (%) 20.4
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 38.03
Total Assets 661.98
Total Liabilities 661.98
Total Equity 307.24
Share Outstanding 449793203
Price to Book Ratio 1.40
Return on Assets (%) 4.88
Return on Capital (%) 10.12
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 31.97
Total Assets 619.38
Total Liabilities 619.38
Total Equity 277.45
Share Outstanding 449793203
Price to Book Ratio 2.80
Return on Assets (%) 4.61
Return on Capital (%) 9.93
Particulars MAR 2023 (Values in Cr)
Net Income 55.75
Cash from Operations -74.61
Cash from Investing -46.50
Cash from Financing 143.54
Net change in Cash 5.86
Free Cash Flow -38.99
Particulars MAR 2022 (Values in Cr)
Net Income 126.70
Cash from Operations -35.30
Cash from Investing -31.67
Cash from Financing 66.33
Net change in Cash -25.58
Free Cash Flow 10.13
Particulars MAR 2021 (Values in Cr)
Net Income 98.51
Cash from Operations 52.28
Cash from Investing -70.35
Cash from Financing 47.27
Net change in Cash 27.74
Free Cash Flow 74.08
Particulars MAR 2020 (Values in Cr)
Net Income 39.10
Cash from Operations 16.89
Cash from Investing -12.46
Cash from Financing 5.48
Net change in Cash 4.04
Free Cash Flow 33.55
Particulars MAR 2019 (Values in Cr)
Net Income 29.17
Cash from Operations 17.71
Cash from Investing -13.05
Cash from Financing -0.44
Net change in Cash 3.87
Free Cash Flow 26.22
Particulars MAR 2023 (Values in Cr)
Net Income 63.04
Cash from Operations -85.84
Cash from Investing -36.19
Cash from Financing 144.19
Net change in Cash 5.88
Free Cash Flow -50.29
Particulars MAR 2022 (Values in Cr)
Net Income 125.54
Cash from Operations -44.47
Cash from Investing -22.64
Cash from Financing 66.41
Net change in Cash -25.09
Free Cash Flow 0.68
Particulars MAR 2021 (Values in Cr)
Net Income 94.24
Cash from Operations 49.31
Cash from Investing -69.08
Cash from Financing 47.46
Net change in Cash 27.68
Free Cash Flow 71.05
Particulars MAR 2020 (Values in Cr)
Net Income 37.48
Cash from Operations 16.37
Cash from Investing -12.07
Cash from Financing 4.64
Net change in Cash 3.43
Free Cash Flow 33.02
Particulars MAR 2019 (Values in Cr)
Net Income 28.61
Cash from Operations 14.57
Cash from Investing -10.33
Cash from Financing -0.35
Net change in Cash 3.89
Free Cash Flow 23.07
Company Name Price P/E P/B Market Cap 52 Week Low/High
MOREPEN LAB. LTD 55.57 29.56 3.35 2840.56 28.51 / 60.75
BLISS GVS PHARMA LTD 115.55 12.63 1.25 1210.24 77.65 / 148.95
CIPLA LTD 1511.95 28.67 4.57 122092.68 1018.30 / 1581.70
FERMENTA BIOTECH LIMITED 198.30 0.00 2.01 583.62 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2570.85 66.33 24.49 43551.75 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
MOREPEN LAB. LTD 55.57 25.61 3.19 2840.56 28.51 / 60.75
AMRUTAJAN HEALTH LTD 751.75 48.31 7.53 2173.36 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6756.05 112.98 23.72 16890.13 3715.05 / 7550.00
BLISS GVS PHARMA LTD 115.55 15.89 1.22 1210.24 77.65 / 148.95
ABBOTT INDIA LIMITED 27481.60 48.62 15.78 58398.40 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 56.90
  • 26 Days 54.40
  • 10 Days 56.80
  • 50 Days 52.90
  • 12 Days 56.70
  • 100 Days 50.80
  • 20 Days 56.00
  • 200 Days 38.30
56.18
PIVOT
First Resistance 56.95
Second Resistance 58.35
Third Resistance 59.12
First Support 54.78
Second Support 54.01
Third Support 52.61
RSI 51.07
MACD 2.31
Commodity Channel Index (CCI) -12.76
ADX 52.94
Williams % R -66.92

Over 1 Month

down

5.84

Over 3 Months

down

20.62

Over 6 Months

down

12.56

Over 1 Year

down

83.94

Over 3 Years

down

-8.02

Over 5 Years

down

26.06

MOREPEN LAB. LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MOREPEN LAB. LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
59.92
Promoter Holdings
38.22
FII
1.85
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Pinfold Overseas Limited Public Shareholding 3.853E7 7.54
Scope Credits And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.5575405E7 3.05
Concept Credits And Consultants Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.5347724E7 3.0
Brook Investments And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.5159252E7 2.97
Solitary Investments And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.5114045E7 2.96
Solace Investments And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.508279E7 2.95
Mid Med Financial Services And Investments Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.4973813E7 2.93
React Investments And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.4942134E7 2.92
Epitome Holdings Pvt.ltd. Shareholding of Promoter and Promoter Group 1.450082E7 2.84
Seed Securities And Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.432878E7 2.8
Square Investments And Financial Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 1.4102075E7 2.76
Sushil Suri Shareholding of Promoter and Promoter Group 5501510.0 1.08
Morepen Laboratories Limited [uncalimed Shares] Public Shareholding 5335298.0 1.04
Anju Suri Shareholding of Promoter and Promoter Group 5186369.0 1.01
Liquid Holdings Pvt. Ltd. Shareholding of Promoter and Promoter Group 5003000.0 0.98
Sonia Pankaj Bajaj Shareholding of Promoter and Promoter Group 3679718.0 0.72
Sanjay Suri Shareholding of Promoter and Promoter Group 3417240.0 0.67
Sunita Suri Shareholding of Promoter and Promoter Group 3192240.0 0.62
Varun Suri Shareholding of Promoter and Promoter Group 3052357.0 0.6
Mamta Suri Shareholding of Promoter and Promoter Group 3004000.0 0.59
Sanjay Suri (sanjay Suri Sons Huf) Shareholding of Promoter and Promoter Group 2100000.0 0.41
Shalu Suri Shareholding of Promoter and Promoter Group 2052250.0 0.4
Anubhav Suri (arun Suri Sons Huf) Shareholding of Promoter and Promoter Group 1500000.0 0.29
Sushil Suri (sushil Suri Sons Huf) Shareholding of Promoter and Promoter Group 1201560.0 0.24
Gulfy Malhotra Shareholding of Promoter and Promoter Group 1150000.0 0.22
Kanak Suri Shareholding of Promoter and Promoter Group 997060.0 0.2
Rajas Suri (kb Suri Sons Huf) Shareholding of Promoter and Promoter Group 972830.0 0.19
Anubhav Suri Shareholding of Promoter and Promoter Group 782134.0 0.15
Aanandi Suri Shareholding of Promoter and Promoter Group 750000.0 0.15
Master Arjun Suri Shareholding of Promoter and Promoter Group 697060.0 0.14
Sara Suri Shareholding of Promoter and Promoter Group 705000.0 0.14
Aanchal Suri Shareholding of Promoter and Promoter Group 685922.0 0.13
P.l. Suri Shareholding of Promoter and Promoter Group 400000.0 0.08
Rajas Suri Shareholding of Promoter and Promoter Group 155000.0 0.03
Aakriti Suri Shareholding of Promoter and Promoter Group 55000.0 0.01
Kanta Suri Shareholding of Promoter and Promoter Group 1510.0 0.0
Praduman Lal Suri Huf Shareholding of Promoter and Promoter Group 2990.0 0.0

MOREPEN LAB. LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2000-11-07 10.0 2.0 2000-11-22 2000-11-06 10.0 2.0 2000-11-22

Learn More About Stocks

About MOREPEN LAB. LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MOREPEN LAB. LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Morepen Laboratories Ltd?

Answer Field

The share price of Morepen Laboratories Ltd for NSE is ₹ 56 and for BSE is ₹ 56.

What is the Market Cap of Morepen Laboratories Ltd?

Answer Field

The market cap of Morepen Laboratories Ltd for NSE is ₹ 2,862.54 Cr. and for BSE is ₹ 2,862.54 Cr. as of now.

What is the 52 Week High and Low of Morepen Laboratories Ltd?

Answer Field

The 52 Week High and Low of Morepen Laboratories Ltd for NSE is ₹ 60.75 and ₹ 28.60 and for BSE is ₹ 60.75 and ₹ 28.51.

How to Buy Morepen Laboratories Ltd share?

Answer Field

You can trade in Morepen Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Morepen Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 83.94%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader